Cargando…
Small-molecule drugs development for Alzheimer's disease
Alzheimer's disease (AD) is an irreversible, progressive neurodegenerative brain disorder with no effective therapeutic drugs currently. The complicated pathophysiology of AD is not well understood, although beta-amyloid (Aβ) cascade and hyperphosphorylated tau protein were regarded as the two...
Autores principales: | Yao, Weiwei, Yang, Huihui, Yang, Jinfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664938/ https://www.ncbi.nlm.nih.gov/pubmed/36389082 http://dx.doi.org/10.3389/fnagi.2022.1019412 |
Ejemplares similares
-
Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023) -
Alzheimer’s disease and epilepsy: An increasingly recognized comorbidity
por: Yang, Fei, et al.
Publicado: (2022) -
Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's Disease
por: Gu, Xuefeng, et al.
Publicado: (2022) -
Systematic analysis of cuproptosis-related genes in immunological characterization and predictive drugs in Alzheimer’s disease
por: Nie, Bin, et al.
Publicado: (2023) -
Olfactory function changes and the predictive performance of the Chinese Smell Identification Test in patients with mild cognitive impairment and Alzheimer's disease
por: Mi, Yan, et al.
Publicado: (2023)